PFS
EBS icon

Prospera Financial Services’s Emergent Biosolutions EBS Stock Holding History

Prospera Financial Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14
Closed -$1K – 1875
2022
Q1 		$1K Buy
+14
New +$617 ﹤0.01% 2595

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Prospera Financial Services's EBS Position: Q2 2022 in Review

Prospera Financial Services sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 14 shares — an estimated $1K sold.

Prospera Financial Services first reported a position in EBS in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

  • Prospera Financial Services reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 14 Emergent Biosolutions shares in Q2 2022, an estimated $1K.
  • Prospera Financial Services first reported a position in Emergent Biosolutions in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Emergent Biosolutions position peaked at $1K in Q1 2022.
  • 232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.